Increased incidence of symptomatic peripheral neuropathy among adults receiving stavudine- versus zidovudine-based antiretroviral regimens in Kenya

Changes in Mitochondrial DNA as a Marker of Nucleoside Toxicity in HIV-Infected Patients

Hélène C. F. Côté, Zabrina L. Brumme, Kevin J.P. Craib et al. · New England Journal of Medicine · 2002 · 572 citations · Full text

Life Sciences, Molecular Biology, Molecular Genetics +12

Continued High Prevalence and Adverse Clinical Impact of Human Immunodeficiency Virus–Associated Sensory Neuropathy in the Era of Combination Antiretroviral Therapy

Ronald J. Ellis · Archives of Neurology · 2010 · 307 citations

Medicine, Infectious Diseases, Neurology +17

Effectiveness and safety of a generic fixed-dose combination of nevirapine, stavudine, and lamivudine in HIV-1-infected adults in Cameroon: open-label multicentre trial

Christian Laurent, Charles Kouanfack, Sinata Koulla‐Shiro et al. · The Lancet · 2004 · 305 citations · Full text

Pharmacy, Pharmacotherapy, Clinical Pharmacology +13

Nucleoside analogue-associated peripheral neuropathy in human immunodeficiency virus infection.

David M. Simpson, Michele Tagliati · PubMed · 1995 · 187 citations

Medicine, Neurology, Pharmacology +17

Modification of the Incidence of Drug-Associated Symmetrical Peripheral Neuropathy by Host and Disease Factors in the HIV Outpatient Study Cohort

Kenneth Lichtenstein, Carl Armon, A. D. Baron et al. · Clinical Infectious Diseases · 2004 · 146 citations · Full text

Medicine, Infectious Diseases, Neurology +17